ArticleJournal of translational medicine2026

EXT2 promotes sarcoma progression and immune evasion via the AKT/c-Myc/PD-L1 axis: a multi-omics and validation study.

Haotian Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.